$10.64-0.07 (-0.65%)
Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East.
Spok Holdings, Inc. in the Healthcare sector is trading at $10.64 with a market capitalization of $231M. The stock is currently near its 52-week low of $9.95, remaining 3.9% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $35.01Mβ | $33.23Mβ | $33.86M | $33.87Mβ | $35.69M |
| Gross Profit | $28.18Mβ | $25.50Mβ | $25.98Mβ | $26.51Mβ | $28.28M |
| Operating Income | $6.97Mβ | $2.77Mβ | $4.15Mβ | $4.53Mβ | $5.41M |
| Net Income | $4.12Mβ | $1.99Mβ | $2.93Mβ | $3.20Mβ | $4.55M |
Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and supp...
Revenue declined but adjusted EBITDA surged 22% on software momentum and cost cuts.
Moby summary of Spok Holdings, Inc.'s Q2 2026 earnings call
Spok Holdings Inc (SPOK) delivered a record adjusted EBITDA and a 92% surge in software bookings, but faces headwinds from longer deal cycles and cautious customer spending.
Spok (NASDAQ:SPOK) reported second-quarter 2026 results marked by higher software bookings, record adjusted EBITDA and continued capital returns to stockholders, while management modestly lowered its full-year revenue outlook amid longer customer sales cycles and demand for shorter contract terms.
Spok (SPOK) delivered earnings and revenue surprises of +33.33% and +2.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?